Abstract
Autoantibodies (AAb), especially antinuclear (ANAs) and anticytoplasmatic antibodies (ACyA), are essential diagnosing markers for several autoimmune diseases. The current gold standard method for ANA detection is manual indirect immunofluorescence (IIF) on human epithelial-2 (HEp-2) cells. However, this technique is cost and time consuming, and characterized by considerable intra- and interlaboratory variability. Thus, an automated IIF-HEp-2 reader has been developed recently. In the current study, we compared the performance of the automated AAb IIF-HEp-2 interpretation to conventional detection methods. Autoantibody detection by IIF on HEp-2 cells was performed in a total of 260 sera of patients, including 34 with systemic lupus erythematosus, 111 with dermatomyositis or polymyositis, 74 with systemic sclerosis, 41 with rare AAb patterns, and 137 healthy individuals. Visual interpretation and routine immunoassays were compared with a novel automated IIF-HEp-2 system using Aklides pattern recognition algorithms. Positive AAbs were detected in 95–100% of rheumatic patients by automated interpretation, in 74–100% with manual reading, and in 64–100% by immunodot assay. Receiver operating characteristic curve analysis of fluorescent intensity revealed a high sensitivity and specificity for automated reading of AAb with an agreement ranging from 90% to 95% between manual and automated interpretation (kappa 0.554–0.69) for systemic sclerosis and myositis, respectively. This study demonstrates a good correlation between manual and automated interpretation of AAb including ANA and ACyA in patients with autoimmune diseases. Full automation of HEp-2 cell assay reading may minimize errors in ANA pattern interpretation and thus help in the standardization of ANA assessment.
Similar content being viewed by others
Abbreviations
- AAb:
-
Autoantibody
- ANA:
-
Antinuclear antibody
- ACyA:
-
Anticytoplasmatic antibody
- IIF:
-
Indirect immunofluorescence
- ELISA:
-
Enzyme-linked immunosorbent immunoassays
- SLE:
-
Systemic lupus erythematosus
- DM:
-
Dermatomyositis
- PM:
-
Polymyositis
- SSc:
-
Systemic sclerosis
- Jo-1:
-
Histidyl-tRNA synthetase
- PL-7:
-
Threonyl-tRNA synthetase
- PL-12:
-
Alanyl-tRNA synthetase
- SRP:
-
Signal recognition particle
- ROC:
-
Receiver operating characteristics
- MSA:
-
Mitotic spindle apparatus
- AUC:
-
Area under curve
References
Fritzler MJ (2008) Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun Rev 7:616–620
Sordet C, Goetz J, Sibilia J (2006) Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint Bone Spine 73:646–654
Worman HJ, Courvalin JC (2003) Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev 2:211–217
Wiik A, Cervera R, Haass M, Kallenberg C, Khamashta M, Meroni PL, Piette JC, Schmitt R, Shoenfeld Y (2006) European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders. Lupus 15:391–396
Lleo A, Invernizzi P, Gao B, Podda M, Gershwin ME (2010) Definition of human autoimmunity—autoantibodies versus autoimmune disease. Autoimmun Rev 9:A259–A266
Agmon-Levin N, Shapira Y, Selmi C, Barzilai O, Ram M, Szyper-Kravitz M, Sella S, Katz BS, Youinou P, Renaudineau Y, Larida B, Invernizzi P, Gershwin ME, Shoenfeld Y (2010) A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun 34:55–58
Arora-Singh RK, Assassi S, del Junco DJ, Arnett FC, Perry M, Irfan U, Sharif R, Mattar T, Mayes MD (2010) Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis. J Autoimmun 35:52–57
Chretien P, Chousterman M, Abd Alsamad I, Ozenne V, Rosa I, Barrault C, Lons T, Hagege H (2009) Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis. J Autoimmun 32:201–205
Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F, Piazza A, Pradella M, Rizzotti P (2002) Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 117:316–324
Hartung K, Seelig HP (2006) Laboratory diagnostics of systemic autoimmune diseases. Part 1. Collagenoses. Z Rheumatol 65:709–722, quiz 723–704
Wiik AS (2005) Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol 34:260–268
Nifli AP, Notas G, Mamoulaki M, Niniraki M, Ampartzaki V, Theodoropoulos PA, Kopnitsky MJ, Castanas E (2006) Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. J Immunol Methods 311:189–197
Smith J, Onley D, Garey C, Crowther S, Cahir N, Johanson A, Painter S, Harradence G, Davis R, Swarbrick P (2005) Determination of ANA specificity using the UltraPlex platform. Ann N Y Acad Sci 1050:286–294
Ghirardello A, Bendo R, Rampudda ME, Bassi N, Zampieri S, Doria A (2009) Commercial blot assays in the diagnosis of systemic rheumatic diseases. Autoimmun Rev 8:645–649
Somers K, Govarts C, Stinissen P, Somers V (2009) Multiplexing approaches for autoantibody profiling in multiple sclerosis. Autoimmun Rev 8:573–579
Liu H, Norman GL, Shums Z, Worman HJ, Krawitt EL, Bizzaro N, Vergani D, Bogdanos DP, Dalekos GN, Milkiewicz P, Czaja AJ, Heathcote EJ, Hirschfield GM, Tan EM, Miyachi K, Bignotto M, Battezzati PM, Lleo A, Leung PS, Podda M, Gershwin ME, Invernizzi P (2010) PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun 35:436–442
Lea P, Keystone E, Mudumba S, Kahama A, Ding SF, Hansen J, Azad AA, Wang S, Weber D (2009) Advantages of multiplex proteomics in clinical immunology: the case of rheumatoid arthritis: novel IgXPLEX: planar microarray diagnosis. Clin Rev Allergy Immunol 41(1):20–35
Rigon A, Soda P, Zennaro D, Iannello G, Afeltra A (2007) Indirect immunofluorescence in autoimmune diseases: assessment of digital images for diagnostic purpose. Cytometry B Clin Cytom 72:472–477
Egerer K, Roggenbuck D, Hiemann R, Weyer MG, Buttner T, Radau B, Krause R, Lehmann B, Feist E, Burmester GR (2010) Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests. Arthritis Res Ther 12:R40
Hiemann R, Hilger N, Michel J, Nitschke J, Bohm A, Anderer U, Weigert M, Sack U (2007) Automatic analysis of immunofluorescence patterns of HEp-2 cells. Ann N Y Acad Sci 1109:358–371
Hiemann R, Buttner T, Krieger T, Roggenbuck D, Sack U, Conrad K (2009) Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmun Rev 9:17–22
Wiik AS, Hoier-Madsen M, Forslid J, Charles P, Meyrowitsch J (2010) Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. J Autoimmun 35:276–290
Admou B, Essaadouni L, Amal S, Arji N, Chabaa L, El Aouad R (2009) Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach. Ann Biol Clin (Paris) 67:273–281
Mierau R, Genth E (2006) Scleroderma associated autoantibodies—clinical and diagnostic relevance. Z Rheumatol 65:279–284
Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93–151
Hachulla E, Launay D (2011) Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol 40(2):78–83
Solomon DH, Kavanaugh AJ, Schur PH (2002) Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 47:434–444
Reshef T, Mekori YA, Mor A (2009) Differential antinuclear antibodies pattern. Isr Med Assoc J 11:123–124
Meroni PL, Schur PH (2010) ANA screening: an old test with new recommendations. Ann Rheum Dis 69:1420–1422
Großmann K, Roggenbuck D, Schröder C, Conrad K, Schierack P, Sack U (2011) Multiplex assessment of non-organ specific autoantibodies with a novel microbead-based immunoassay. Cytometry A 79(2):118–125
Disclosures
Dirk Roggenbuck has a management role and is a shareholder of GA Generic Assays GmbH and Medipan GmbH. Both companies are diagnostic manufacturers. All other authors declare that they have no competing financial interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
Shaye Kivity and Boris Gilburd have equally contributed.
Rights and permissions
About this article
Cite this article
Kivity, S., Gilburd, B., Agmon-Levin, N. et al. A novel automated indirect immunofluorescence autoantibody evaluation. Clin Rheumatol 31, 503–509 (2012). https://doi.org/10.1007/s10067-011-1884-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-011-1884-1